Family history of colorectal cancer: A determinant of advanced adenoma stage or adenoma multiplicity?

International Journal of Cancer

Volumn 125, Issue 2, 2009, Pages 413-420

  Wark, Petra A ^a,b   Wu, Kana ^c   Van 't Veer, Pieter ^b   Fuchs, Charles F ^d,e   Giovannucci, Edward L ^c,f  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d HARVARD CENTER FOR CANCER PREVENTION   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cohort study; Colorectal adenomas; Colorectal cancer; Colorectal neoplasm; Family history

Indexed keywords

ACETYLSALICYLIC ACID;

ADENOMA; ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; ENDOSCOPY; FAMILY HISTORY; HUMAN; LIFESTYLE; LIVER ADENOMA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RECTUM ADENOMA; RISK FACTOR; TUMOR LOCALIZATION; TUMOR VOLUME; VILLOUS ADENOMA; COLORECTAL TUMOR; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED;

ADENOMA; AGED; COLORECTAL NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES;

EID: 67449103803     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24288     Document Type: Article

References (39)

1. Butterworth AS, Higgins JP, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer 2006;42:216-27.
2. Baglietto L, Jenkins MA, Severi G, Giles GG, Bishop DT, Boyle P, Hopper JL. Measures of familial aggregation depend on definition of family history: meta-analysis for colorectal cancer. J Clin Epidemiol 2006;59:114-24.
3. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden. Denmark, and. Finland. N Engl J Med 2000;343:78-85.
4. De la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer 2004;4:769-80.
5. Almendingen K, Hofstad B, Vatn MH. Does a family history of cancer increase the risk of occurrence, growth, and recurrence of colorectal adenomas? Gut 2003;52:747-51.
6. Boutron MC, Faivre J, Quipourt V, Senesse P, Michiels C. Family history of colorectal tumours and implications for the adenoma-carcinoma sequence: a case control study. Gut 1995;37:830-4.
7. Pariente A, Milan C, Lafon J, Faivre J. Colonoscopic screening in first-degree relatives of patients with 'sporadic' colorectal cancer: a case-control study. The. Association. Nationale des. Gastroenterologues des. Hopitaux and. Registre. Bourguignon des. Cancers. Digestifs (INSERM CRI 9505). Gastroenterology 1998;115:7-12.
8. Guillem JG, Forde KA, Treat MR, Neugut AI, O'Toole KM, Diamond BE. Colonoscopic screening for neoplasms in asymptomatic first-degree relatives of colon cancer patients. A controlled, prospective study. Dis Colon Rectum 1992;35:523-9.
9. Bazzoli F, Fossi S, Sottili S, Pozzato P, Zagari RM, Morelli MC, Taroni F, Roda E. The risk of adenomatous polyps in asymptomatic first-degree relatives of persons with colon cancer. Gastroenterology 1995;109:783-8.
10. Tung SY, Wu CS. Risk factors for colorectal adenomas among immediate family members of patients with colorectal cancer in Taiwan: a case-control study. Am J Gastroenterol 2000;95:3624-8.
11. Terry MB, Neugut AI, Bostick RM, Sandler RS, Haile RW, Jacobson JS, Fenoglio-Preiser CM, Potter JD. Risk factors for advanced colorectal adenomas: a pooled analysis. Cancer Epidemiol Biomarkers Prev 2002;11:622-9.
12. Kerber RA, Slattery ML. Comparison of self-reported and database-linked family history of cancer data in a case-control study. Am J Epidemiol 1997;146:244-8.
13. Murff HJ, Spigel DR, Syngal S. Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA 2004;292:1480-9.
14. Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 1992;135:1114-26; discussion 27-36.
15. Willett W. Nutritional epidemiology, 2nd ed. New York, NY: Oxford University Press, 1998.
16. Hu FB, Manson JE, Liu S, Hunter D, Colditz GA, Michels KB, Speizer FE, Giovannucci E. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 1999;91:542-7.
17. Begg CB, Gray R. Calculation of polychotomous logistic-regression parameters using individualized regressions. Biometrika 1984;71:11-18.
18. Ainsworth BE, Haskell WL, Leon AS, Jacobs DR Jr. Montoye HJ, Sallis JF, Paffenbarger RS Jr. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 1993;25:71-80.
19. Armitage P, Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. 1954. Int J Epidemiol 2004;33:1174-9.
20. Hemminki K, Chen B. Familial risk for colorectal cancers are mainly due to heritable causes. Cancer Epidemiol Biomarkers Prev 2004;13:1253-6.
21. Bond JH. Polyp guideline: diagnosis, treatment, and surveillance for patients with colorectal polyps. Practice parameters committee of the American College of Gastroenterology. Am J Gastroenterol 2000;95:3053-63.
22. Rex DK, Cutler CS, Lemmel GT, Rahmani EY, Clark DW, Helper DJ, Lehman GA, Mark DG. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997;112:24-8.
23. Winawer SJ, Zauber AG, Fletcher RH, Stillman JS, O'Brien MJ, Levin B, Smith RA, Lieberman DA, Burt RW, Levin TR, Bond JH, Brooks D, et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin 2006;56:143-59; quiz 84-5.
24. Jensen P, Krogsgaard MR, Christiansen J, Braendstrup O, Johansen A, Olsen J. Observer variability in the assessment of type and dysplasia of colorectal adenomas, analyzed using kappa statistics. Dis Colon Rectum 1995;38:195-8.
25. Terry MB, Neugut AI, Bostick RM, Potter JD, Haile RW, Fenoglio-Preiser CM. Reliability in the classification of advanced colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2002;11:660-3.
26. Costantini M, Sciallero S, Giannini A, Gatteschi B, Rinaldi P, Lanzanova G, Bonelli L, Casetti T, Bertinelli E, Giuliani O, Castiglione G, Mantellini P, et al. Interobserver agreement in the histologic diagnosis of colorectal polyps. the experience of the multicenter adenoma colorectal study (SMAC). J Clin Epidemiol 2003;56:209-14.
27. O'Brien H, Matthew JA, Gee JM, Watson M, Rhodes M, Speakman CT, Stebbings WS, Kennedy HJ, Johnson IT. K-ras mutations, rectal crypt cells proliferation, and meat consumption in patients with left-sided colorectal carcinoma. Eur J Cancer Prev 2000;9:41-7.
28. Gschwantler M, Kriwanek S, Langner E, Goritzer B, Schrutka-Kolbl C, Brownstone E, Feichtinger H, Weiss W. High-grade dysplasia and invasive carcinoma in colorectal adenomas: a multivariate analysis of the impact of adenoma and patient characteristics. Eur J Gastroenterol Hepatol 2002;14:183-8.
29. Jørgensen OD, Kronborg O, Fenger C. The funen adenoma follow-up study. Characteristics of patients and initial adenomas in relation to severe dysplasia. Scand J Gastroenterol 1993;28:239-43.
30. Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willett WC. A prospective study of family history and the risk of colorectal cancer. N Engl J Med 1994;331:1669-74.
31. Stevens RG, Swede H, Heinen CD, Jablonski M, Grupka M, Ross B, Parente M, Tirnauer JS, Giardina C, Rajan TV, Rosenberg DW, Levine J. Aberrant crypt foci in patients with a positive family history of sporadic colorectal cancer. Cancer Lett 2007;248:262-8.
32. Church JM. A scoring system for the strength of a family history of colorectal cancer. Dis Colon Rectum 2005;48:889-96.
33. Houlston R, Crabtree M, Phillips R, Crabtree M, Tomlinson I. Explaining differences in the severity of familial adenomatous polyposis and the search for modifier genes. Gut 2001;48:1-5.
34. Hao CY, Moore DH, Wong P, Bennington JL, Lee NM, Chen LC. Alteration of gene expression in macroscopically normal colonic mucosa from individuals with a family history of sporadic colon cancer. Clin Cancer Res 2005;11:1400-7.
35. Iacopetta B. Are there two sides to colorectal cancer?. Int J Cancer 2002;101:403-8.
36. Giardiello FM, Brensinger JD, Luce MC, Petersen GM, Cayouette MC, Krush AJ, Bacon JA, Booker SV, Bufill JA, Hamilton SR. Phenotypic expression of disease in families that have mutations in the 50 region of the adenomatous polyposis coli gene. Ann Intern Med 1997;126:514-9.
37. Fossi S, Bazzoli F, Ricciardiello L, Nicolini G, Zagari RM, Pozzato P, Palli D, Roda E. Incidence and recurrence rates of colorectal adenomas in first-degree asymptomatic relatives of patients with colon cancer. Am J Gastroenterol 2001;96:1601-4.
38. Ahlquist DA. Aggressive polyps in hereditary nonpolyposis colorectal cancer: targets for screening. Gastroenterology 1995;108:1590-2.
39. Loeve F, Boer R, Zauber AG, Van Ballegooijen M, Van Oortmarssen GJ, Winawer SJ, Habbema JD. National Polyp Study data: evidence for regression of adenomas. Int J Cancer 2004;111:633-9.